Keratoconus Treatment Market Size & Share, by End user (Hospital, Eye Clinics); Treatment Type; Type - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

North America Market Statistics

North America in keratoconus treatment market is anticipated to hold more than 33.5% revenue share by 2037. The increasing number of keratoconus diagnoses, particularly among young adults, is driving demand for effective treatments. Improved awareness and advanced diagnostic technologies are enabling earlier and more accurate detection, further boosting treatment adoption. Innovations like corneal cross-linking, scleral lenses, and intracorneal ring segments (ICRS) have improved vision correction and slowed progression in keratoconus, encouraging more patients to seek effective treatments.

With an aging population in the U.S., age-related eye conditions such as keratoconus are becoming more common, driving the demand for treatment. As older adults are more susceptible to eye diseases, they seek appropriate treatments to maintain vision quality. New surgical techniques, including implantable contact lenses and keratoplasty (corneal transplantation), are becoming more advanced and effective. The total number of corneal transplants rose from 47,903 in 2015 to 49,143 in 2019, according to a November 2023 NIH publication. These innovations attract patients who require more permanent solutions, thus contributing to keratoconus treatment market expansion.

As awareness of keratoconus increases, more cases are being diagnosed in Canada. The condition's prevalence, though rare, is growing due to better diagnostic techniques and a greater understanding of eye disorders, prompting demand for effective treatments. Advanced treatments such as corneal cross-linking, riboflavin / UV therapy, and innovative contact lenses have improved keratoconus outcomes, enhanced patients' quality of life, and driven market growth.

APAC Market Analysis

In Asia Pacific, the keratoconus treatment market is established to garner fastest market growth over the forecast period. The region reports a substantial number of keratoconus cases, with prevalence rates varying significantly across countries. These figures underscore the growing demand for effective treatments tailored to the diverse populations within Asia Pacific. Moreover, ongoing enhancements in healthcare facilities and services across the Asia Pacific are facilitating better growth in the keratoconus treatment market.

China reports a substantial number of keratoconus cases, leading to increased demand for effective treatments. The government of China focuses on improving healthcare infrastructure and reimbursement policies for advanced medical devices creating a favorable environment for market growth. Additionally, the government of China has set up a healthcare insurance program that benefits over 1.36 billion people and covers nearly 96% of the population as published by the National Library of Medicine in May 2023.  ongoing research and development have led to the introduction of innovative treatment options, enhancing the effectiveness and accessibility of keratoconus therapies

India is embarking on significant growth in the keratoconus treatment market due to rising disposable income and healthcare spending. Economic growth has increased disposable, enabling more individuals to seek advanced medical treatments, including those for keratoconus. In January 2024, the International Trade Administration reported that the healthcare sector in India had grown to nearly USD 370 billion in 2022. Further, innovative treatments such as corneal cross-linking and specialized contact lenses have significantly enhanced keratoconus management. Corneal cross-linking stabilizes the cornea, halting disease progression and improving vision. Specialized contact lenses correct refractive errors, offering clearer vision and increased comfort. These advancements provide patients with more effective and personalized therapeutic options, thus propelling the market.